Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.58 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.58 |
| ▸ | PLA2G2C | Q5R387 | 3/20 | 0.47 |
| ▸ | TLR2 | O60603 | 2/20 | 0.46 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.45 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.45 |
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.44 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.44 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | LCK | P06239 | 1/20 | 0.42 |
| ▸ | PPARD | Q03181 | 1/20 | 0.42 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.42 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.42 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.41 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20435333 | 0.98 | SIRT6 (0.55) | SIRT6SIRT1PLA2G2CTLR2PLA2G2A | |
| SCHEMBL14978808 | 0.98 | SIRT6 (0.55) | SIRT6SIRT1PLA2G2CTLR2PLA2G2A | |
| SCHEMBL13525107 | 0.92 | SIRT6 (0.49) | SIRT6SIRT1PLA2G2CTLR2NOD1 | |
| SCHEMBL10603414 | 0.86 | NOD1 (0.60) | SIRT6SIRT1NOD1GPR84FFAR1 | |
| SCHEMBL21801849 | 0.86 | NOD1 (0.60) | SIRT6SIRT1NOD1GPR84FFAR1 | |
| SCHEMBL10600983 | 0.86 | NOD1 (0.60) | SIRT6SIRT1NOD1GPR84FFAR1 | |
| SCHEMBL4609045 | 0.86 | NOD1 (0.60) | SIRT6SIRT1NOD1GPR84FFAR1 | |
| SCHEMBL10599643 | 0.86 | NOD1 (0.60) | SIRT6SIRT1NOD1GPR84FFAR1 | |
| SCHEMBL10599977 | 0.86 | NOD1 (0.60) | SIRT6SIRT1NOD1GPR84FFAR1 | |
| SCHEMBL10603409 | 0.86 | NOD1 (0.60) | SIRT6SIRT1NOD1GPR84FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12043637-B2 | Fluorescent dyes containing bis-boron fused heterocycles and uses in sequencing | ILLUMINA CAMBRIDGE LIMITED (GB) | 2024-07-23 | — | — | US | disclosed |
| US-20230304086-A1 | LABELED AVIDIN AND METHODS FOR SEQUENCING | ILLUMINA CAMBRIDGE LIMITED (GB) | 2023-09-28 | — | — | US | disclosed |
| US-20120202287-A1 | Stem Cell Culture Methods | ITI SCOTLAND LIMITED (GB) | 2012-08-09 | — | — | US | disclosed |
| EP-2389436-A2 | STEM CELL CULTURE METHODS | ITI Scotland Limited (GB) | 2011-11-30 | — | — | EP | disclosed |
| US-20110257911-A1 | SYSTEMS AND METHODS FOR DETECTING CHANGES IN ENERGY USAGE IN A BUILDING | JOHNSON CONTROLS TECHNOLOGY COMPANY | 2011-10-20 | — | — | US | disclosed |
| WO-2010084300-A2 | STEM CELL CULTURE METHODS | ITI SCOTLAND LIMITED (GB) | 2010-07-29 | — | — | WO | disclosed |
| EP-0009154-B1 | COMPLEXES OF 9-HYDROXYALKYL-PURINES, PROCESSES FOR PREPARING THEM AND THERAPEUTICAL COMPOSITIONS CONTAINING THE COMPLEXES AS ACTIVE INGREDIENTS | Newport Pharmaceuticals International, Inc. (US) | 1982-12-08 | — | — | EP | disclosed |
| EP-0009155-B1 | 9-HYDROXYALKYL-PURINES, PROCESSES FOR PREPARING THEM AND THERAPEUTICAL COMPOSITION CONTAINING THE 9-HYDROXYALKYL-PURINES AS ACTIVE INGREDIENTS | Newport Pharmaceuticals International, Inc. (US) | 1982-11-17 | — | — | EP | disclosed |
| US-4221794-A | Method of imparting immunomodulating and antiviral activity | NEWPORT PHARMACEUTICALS INTERNATIONAL, INC. (US) | 1980-09-09 | — | — | US | disclosed |
| US-4221909-A | P-Acetamidobenzoic acid salts of 9-(hydroxyalkyl) purines | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1980-09-09 | — | — | US | disclosed |
| US-4221910-A | IMMUNOPOTENTIATORS, VIRICIDES, ANTILEUKEMIA AGENTS | NEWPORT PHARMACEUTICALS INTERNATIONAL, INC. (US) | 1980-09-09 | — | — | US | disclosed |
| EP-0009155-A1 | 9-Hydroxyalkyl-purines, processes for preparing them and therapeutical composition containing the 9-hydroxyalkyl-purines as active ingredients | Newport Pharmaceuticals International, Inc. (US) | 1980-04-02 | — | — | EP | disclosed |
| EP-0009154-A1 | Complexes of 9-hydroxyalkyl-purines, processes for preparing them and therapeutical compositions containing the complexes as active ingredients | Newport Pharmaceuticals International, Inc. (US) | 1980-04-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12043637-B2 | Fluorescent dyes containing bis-boron fused heterocycles and uses in sequencing | BLVRB, BCDIN3D, FOSB | SIRT6 2892/4885SIRT1 3455/4885PLA2G2C 4457/4885 |
| US-20230304086-A1 | LABELED AVIDIN AND METHODS FOR SEQUENCING | ANXA6, ANXA3, BCDIN3D | SIRT6 3723/4885SIRT1 4729/4885PLA2G2C 3693/4885 |
| US-20120202287-A1 | Stem Cell Culture Methods | KIT, SOX18, MCL1 | SIRT6 2660/4885SIRT1 1015/4885PLA2G2C 3405/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.